This study aims to compare the efficacy of intralesional triamcinolone and verapamil in patients presenting with keloid at our local setting. The results will guide us towards better management of keloids by choosing the more appropriate treatment. Adequate treatment will reduce significant emotional and physical distress in patients. We hypothesized that mean reduction in Vancouver Scar Score is higher in triamcinolone acetonide group compared to verapamil after three months of treatment.

Inclusion Criteria:

• size of keloid1-5 cm,
• on any site of the body,
• duration less then five years and
• baseline Vancouver scar score of more the or equal to 5

Exclusion Criteria:

• Pregnant or lactating women,
• family history of keloids,
• acromegaly, and
• congestive cardiac diseases

Individual participant data (IPD) will not be shared to protect patient confidentiality and comply with ethical and regulatory guidelines. Additionally, the study design does not include provisions for public data sharing.